Medical News

RSS

Novel anti-leukemia compound with little toxicity successfully treats zebrafish

A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans - even those resistant to conventional therapies - according to results from a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

9 Apr 2012

GYT campaign kicks off National STD Awareness Month

The fourth annual GYT: Get Yourself Tested campaign kicks off National STD Awareness Month (April) with new initiatives on-air, online, and on the ground at college campuses and in more than 5,000 health centers across the nation.

9 Apr 2012

During the congressional break, voters air their frustrations

At a time of high unemployment and home foreclosure rates, frustration with Congress and rising anxiety over how to deal with the national debt without gutting programs such as Medicare health insurance for the elderly and the Social Security retirement program, such meetings aren't always comfortable for lawmakers.

9 Apr 2012

DMI awarded contract to modernize and maintain HHS OIG's enterprise applications

DMI, a leading IT solutions and business strategy consulting firm, today announced that it has been awarded a multi-million dollar contract to modernize and maintain the suite of enterprise applications used by the Department of Health and Human Services (HHS) Office of Inspector General (OIG). This is DMI's fourth prime contract with HHS in the last 18 months.

9 Apr 2012

Synapse Medical acquires another MicroThermX Microwave Ablation System

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has sold an additional MicroThermX Microwave Ablation System to Synapse Medical Ltd.

9 Apr 2012

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells.

9 Apr 2012

Bimodal genes can define molecular subtypes of ovarian cancer

Scientists from Duke University Medical Center have determined that genes acting as molecular "on/off" switches can define clinically relevant molecular subtypes of ovarian cancer, providing ideal potential targets for use in clinical prognostic and diagnostic testing.

9 Apr 2012

New text messaging program to manage diabetes

D.C. Chartered Health Plan, Inc., the oldest Medicaid managed care organization in the District of Columbia, is launching a new text messaging program for 50 of its members to help them better manage diabetes, which requires regular care to avoid costly complications.

9 Apr 2012

Blog posts respond to Melinda Gates' TEDxChange presentation

The Bill & Melinda Gates Foundation's "Impatient Optimists" blog published several posts in response to the TEDxChange: "The Big Picture" presentation delivered by Melinda Gates, co-chair of the foundation, in Berlin on Thursday.

9 Apr 2012

Chemotherapy based on individual genomes and genomes of tumors

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

9 Apr 2012

Idaho's adoption of NPLEx to block illegal methamphetamine sales receives praise

The Consumer Healthcare Products Association (CHPA) today applauded Idaho Governor C.L. "Butch" Otter for signing into law real-time, stop-sale technology called the National Precursor Log Exchange (NPLEx) which allows check-out clerks to block illegal pseudoephedrine purchases right at the point of sale and provides law enforcement with valuable criminal data up to the minute.

9 Apr 2012

A step closer to correcting unhealthy gene mutations with diet

Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS.

9 Apr 2012

States count health law dollars, brace for back-ups if overhaul struck down

In health law implementation news, Iowa gets federal grants for home care workers to visit families with children while Minnesota lawmakers brace for losing Medicaid dollars.

9 Apr 2012

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Bioness Inc. today announced the initiation of a study to evaluate the safety and effectiveness of the company's StimRouter Neuromodulation System for those suffering from chronic peripheral nerve pain. This prospective, multi-center, randomized, double-blinded, partial crossover study will enroll 126 patients at up to 10 study sites throughout the United States.

9 Apr 2012

Japanese MHLW approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

9 Apr 2012

Five significant genetic associations for hypothyroidism found

Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.

9 Apr 2012

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

Winston Pharmaceuticals, Inc.,, announced that the National Institutes of Health has awarded Winston a grant under the Small Business Innovation Research program supporting the development of Civamide, a proprietary TRPV-1 receptor modulator, for the treatment of postherpetic neuralgia of the trigeminal nerve.

9 Apr 2012

On the campaign trail, it seems everyone has critics

According to reports, the Obama administration continues to face stiff criticism from Catholic leaders over its contraception policies. Meanwhile, GOP presidential hopeful Mitt Romney has among his health policy advisers two people who are on the record in their opposition to the health he signed while governor of Massachusetts.

9 Apr 2012

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

Niacin, or vitamin B3, is the one approved drug that elevates "good" cholesterol (high density lipoprotein, HDL) while depressing "bad" cholesterol (low density lipoprotein , LDL), and has thereby attracted much attention from patients and physicians. Niacin keeps fat from breaking down, and so obstructs the availability of LDL building blocks.

9 Apr 2012

Heart cells starved of nutrients less likely to be damaged during ischemia, reperfusion

Heart cells starved of nutrients are less likely to be damaged during periods of decreased blood flow and sudden influxes of blood, known as ischemia and reperfusion, and are also less likely to get out of synch with their cellular neighbors, the damaging phenomenon called arrhythmia.

9 Apr 2012